Joannides R, Bakkali E H, Le Roy F, Rivault O, Godin M, Moore N, Fillastre J P, Thuillez C
Department of Pharmacology, VACOMED, IFRMP 23, Rouen University Medical School, France.
Nephrol Dial Transplant. 1997 Dec;12(12):2623-8. doi: 10.1093/ndt/12.12.2623.
An altered arterial nitric oxide (NO) pathway could partly explain the damage to arteries observed in haemodialyzed (HD) patients. The present study was designed to non-invasively evaluate the NO pathway of peripheral conduit arteries in HD patients.
Twelve normotensive, non-diabetic HD patients treated with erythropoietin and 12 matched healthy controls (C) were included in the study. The effect of endogenous release of NO was assessed by measuring the flow-dependent vasodilatation of the radial artery (post-ischaemic hyperaemia), and the response to exogenous NO assessed using sublingual glyceryl trinitrate administration (GTN).
Radial artery diameter (echo-tracking), radial blood flow (RBF: Doppler) and mean arterial pressure (Finapres) were identical at baseline in HD patients and in healthy subjects. The flow-dependent vasodilatation of the radial artery was decreased in HD patients (C: 9 +/- 1% vs HD: 3 +/- 05%, P < 0.05). The decrease in radial vascular resistance (C: -44 +/- 4% vs HD: -24 +/- 2%, P < 0.05) and the increase in radial diameter (C: 31 +/- 2% vs HD: 25 +/- 2%, P < 0.05) after GTN administration were less in HD patients than in controls. The ratio between the increase in diameter after hyperaemia to the increase in diameter after GTN, was also diminished in HD patients (C: 30 +/- 3% vs HD: 13 +/- 2%, P < 0.001).
The flow-dependent vasodilatation of peripheral conduit arteries is altered in HD patients and is associated with a slight but significant decrease in the vasodilating response to exogenous NO. These results suggest, in the absence of changes in basal radial vascular resistance and arterial diameter, more a decrease in endothelial NO bioavailability, than an increase in basal vascular tone.
动脉一氧化氮(NO)途径改变可能部分解释血液透析(HD)患者中观察到的动脉损伤。本研究旨在非侵入性评估HD患者外周传导动脉的NO途径。
本研究纳入了12名接受促红细胞生成素治疗的血压正常、非糖尿病的HD患者以及12名匹配的健康对照(C)。通过测量桡动脉的血流依赖性血管舒张(缺血后充血)评估内源性NO释放的作用,并通过舌下含服硝酸甘油(GTN)评估对外源性NO的反应。
HD患者和健康受试者在基线时桡动脉直径(回声跟踪)、桡动脉血流(RBF:多普勒)和平均动脉压(Finapres)相同。HD患者桡动脉的血流依赖性血管舒张降低(C组:9±1% vs HD组:3±0.5%,P<0.05)。HD患者服用GTN后桡动脉血管阻力的降低(C组:-44±4% vs HD组:-24±2%,P<0.05)和桡动脉直径的增加(C组:31±2% vs HD组:25±2%,P<0.05)均低于对照组。HD患者充血后直径增加与GTN后直径增加的比值也降低(C组:30±3% vs HD组:13±2%,P<0.001)。
HD患者外周传导动脉的血流依赖性血管舒张发生改变,并且与对外源性NO的血管舒张反应轻微但显著降低有关。这些结果表明,在基础桡动脉血管阻力和动脉直径无变化的情况下,更多的是内皮NO生物利用度降低,而非基础血管张力增加。